Citations (139)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Sefli Sri Wahyu Effendi & I-Son Ng. (2023) Prospective and challenges of live bacterial therapeutics from a superhero Escherichia coli Nissle 1917. Critical Reviews in Microbiology 49:5, pages 611-627.
Read now
Read now
Benedikt M. Mortzfeld, Jacob D. Palmer, Shakti K. Bhattarai, Haley L. Dupre, Regino Mercado-Lubio, Mark W. Silby, Corinna Bang, Beth A. McCormick & Vanni Bucci. (2022) Microcin MccI47 selectively inhibits enteric bacteria and reduces carbapenem-resistant Klebsiella pneumoniae colonization in vivo when administered via an engineered live biotherapeutic. Gut Microbes 14:1.
Read now
Read now
Razan ZeinEddine, Nivin Nasser, Issmat Kassem & I. Patrick Saoud. (2022) Effect of the Human Probiotic Bacterium Escherichia coli Nissle (1917) on performance and immune response of Nile tilapia Oreochromis niloticus. Journal of Applied Aquaculture 34:3, pages 527-541.
Read now
Read now
Jiwon Hong, Priscila Dauros-Singorenko, Alana Whitcombe, Leo Payne, Cherie Blenkiron, Anthony Phillips & Simon Swift. (2019) Analysis of the Escherichia coli extracellular vesicle proteome identifies markers of purity and culture conditions. Journal of Extracellular Vesicles 8:1.
Read now
Read now
Stellah Byakika, Ivan Muzira Mukisa, Yusuf Byenkya Byaruhanga & Charles Muyanja. (2019) A Review of Criteria and Methods for Evaluating the Probiotic Potential of Microorganisms. Food Reviews International 35:5, pages 427-466.
Read now
Read now
Wenxing Zhu, Lujiang Hao, Xinli Liu, Orlando Borrás-Hidalgo & Yuyu Zhang. (2018) Enhanced anti-proliferative efficacy of epothilone B loaded with Escherichia coli Nissle 1917 bacterial ghosts on the HeLa cells by mitochondrial pathway of apoptosis. Drug Development and Industrial Pharmacy 44:8, pages 1328-1335.
Read now
Read now
Jacqueline Montanaro, Aleksandra Inic-Kanada, Angela Ladurner, Elisabeth Stein, Sandra Belij, Nora Bintner, Simone Schlacher, Nadine Schuerer, Ulrike Beate Mayr, Werner Lubitz, Nikolaus Leisch & Talin Barisani-Asenbauer. (2015) Escherichia coli Nissle 1917 bacterial ghosts retain crucial surface properties and express chlamydial antigen: an imaging study of a delivery system for the ocular surface. Drug Design, Development and Therapy 9, pages 3741-3754.
Read now
Read now
Marika Mikelsaar, Veronica Lazar, Andrew Onderdonk & Gilanfranco Donelli. (2011) Do probiotic preparations for humans really have efficacy?. Microbial Ecology in Health and Disease 22:1.
Read now
Read now
Articles from other publishers (131)
Matthew Lebovich, Min Zeng & Lauren B. Andrews. (2023) Algorithmic Programming of Sequential Logic and Genetic Circuits for Recording Biochemical Concentration in a Probiotic Bacterium. ACS Synthetic Biology 12:9, pages 2632-2649.
Crossref
Crossref
Tuo Zhang, Shuo Geng, Tiantian Cheng, Kemin Mao, Bimal Chitrakar, Jie Gao & Yaxin Sang. (2023) From the past to the future: Fermented milks and their health effects against human diseases. Food Frontiers.
Crossref
Crossref
Guixia Yang, Lingkang Yang & Xianxuan Zhou. (2023) Inhibition of bacterial swimming by heparin binding of flagellin FliC from Escherichia coli strain Nissle 1917. Archives of Microbiology 205:8.
Crossref
Crossref
AMIN ULLAH, AQIB BASHIR, BILAL REHMAN, WAFA NAEEM & SAMAN ZARA SHAH. (2023) OPTIMIZATION OF COLONY POLYMERASE CHAIN REACTION FOR THE 16SRRNA OF DIFFERENT STRAINS OF ESCHERICHIA COLI. Innovare Journal of Life Sciences, pages 32-35.
Crossref
Crossref
Garima Mishra, Pradeep Singh, Mulugeta Molla, Yohannes Shumet Yimer, Subas Chandra Dinda, Phool Chandra, Bhuvnesh Kumar Singh, Samuel Berihun Dagnew, Abraham Nigussie Assefa & Amien Ewunetie. (2023) Harnessing the potential of probiotics in the treatment of alcoholic liver disorders. Frontiers in Pharmacology 14.
Crossref
Crossref
Ziyang Zhu, Qingyao Liu, Ke Zhu, Kun Wang, Lan Lin, Yaqi Chen, Fuqiang Shao, Ruijie Qian, Yangmeihui Song, Yu Gao, Biao Yang, Dawei Jiang, Xiaoli Lan & Rui An. (2023) Aggregation-Induced Emission Photosensitizer/Bacteria Biohybrids Enhance Cerenkov Radiation-Induced Photodynamic Therapy by Activating Anti-Tumor Immunity for Synergistic Tumor Treatment. Acta Biomaterialia.
Crossref
Crossref
S. Ramadevi, Ruby Shelin & Meenakshi Shanmugaraja. (2023) Comprehensive Analysis of the Physiological Characterization of Escherichia coli Nissle 1917. Current Microbiology 80:5.
Crossref
Crossref
Ying Liu, Mengmeng Zhang, Xinyue Wang, Fengmin Yang, Zhenping Cao, Lu Wang & Jinyao Liu. (2023) Dressing Bacteria With a Hybrid Immunoactive Nanosurface to Elicit Dual Anticancer and Antiviral Immunity. Advanced Materials 35:11, pages 2210949.
Crossref
Crossref
Zhiqiang Xiong, Xuejiao Zhang, Jason C. White, Liwei Liu, Weimin Sun, Siyu Zhang, Jin Zeng, Shuo Deng, Daxu Liu, Xiaoli Zhao, Fengchang Wu, Qing Zhao & Baoshan Xing. (2023)
Transcriptome Analysis Reveals the Growth Promotion Mechanism of Enteropathogenic
Escherichia coli
Induced by Black Phosphorus Nanosheets
. ACS Nano 17:4, pages 3574-3586.
Crossref
Crossref
Zhenping Cao, Rui Liu, Chuhan Wang, Sisi Lin, Lu Wang & Yan Pang. (2023) Fluorescence-Activating and Absorption-Shifting Nanoprobes for Anaerobic Tracking of Gut Microbiota Derived Vesicles. ACS Nano.
Crossref
Crossref
Aida Kalantari, Michael J. James, Lauren A. Renaud, Mylene Perreault, Catherine E. Monahan, Mary N. McDonald, David L. Hava & Vincent M. Isabella. (2023) Robust performance of a live bacterial therapeutic chassis lacking the colibactin gene cluster. PLOS ONE 18:2, pages e0280499.
Crossref
Crossref
Xiaoqiang Zhu, Sihan Chen, Xiuwen Hu, Lijun Zhao, Yiqian Wang, Jinzhao Huang, Jiawen Chen, Yuzhi Qiu, Xuefei Zhang, Mengdie Wang, Xiangliang Yang, Yan Zhang & Yanhong Zhu. (2022) Near‐Infrared Nano‐Optogenetic Activation of Cancer Immunotherapy via Engineered Bacteria. Advanced Materials 35:8.
Crossref
Crossref
Chrysoula Dimopoulou, Mareike Bongers, Mikael Pedersen, Martin I Bahl, Morten O A Sommer, Martin F Laursen & Tine R Licht. (2023)
An engineered
Escherichia coli
Nissle 1917 increase the production of indole lactic acid in the gut
. FEMS Microbiology Letters 370.
Crossref
Crossref
Jiaqi Xu, Junchao Xu, Tongfei Shi, Yinlong Zhang, Fangman Chen, Chao Yang, Xinjing Guo, Guangna Liu, Dan Shao, Kam W. Leong & Guangjun Nie. (2022) Probiotic‐Inspired Nanomedicine Restores Intestinal Homeostasis in Colitis by Regulating Redox Balance, Immune Responses, and the Gut Microbiome. Advanced Materials 35:3.
Crossref
Crossref
Max van ‘t Hof, Omkar S. Mohite, Jonathan M. Monk, Tilmann Weber, Bernhard O. Palsson & Morten O. A. Sommer. (2022) High-quality genome-scale metabolic network reconstruction of probiotic bacterium Escherichia coli Nissle 1917. BMC Bioinformatics 23:1.
Crossref
Crossref
Marta Domínguez-Maqueda, Olivia Pérez-Gómez, Ana Grande-Pérez, Consuelo Esteve, Pedro Seoane, Silvana T. Tapia-Paniagua, Maria Carmen Balebona & Miguel Angel Moriñigo. (2022)
Pathogenic strains of
Shewanella putrefaciens
contain plasmids that are absent in the probiotic strain Pdp11
. PeerJ 10, pages e14248.
Crossref
Crossref
Yan Huang, Xiaojun Lin, Siyang Yu, Ruiyue Chen & Weizhao Chen. (2022) Intestinal Engineered Probiotics as Living Therapeutics: Chassis Selection, Colonization Enhancement, Gene Circuit Design, and Biocontainment. ACS Synthetic Biology 11:10, pages 3134-3153.
Crossref
Crossref
Jiali Yang, Guizhen Zhang, Xinyuan Yang, Mengyun Peng, Shengchan Ge, Shaochong Tan, Zhiyang Wen, Yifei Wang, Sixuan Wu, Yan Liang, Jingyi An, Kaixiang Zhang, Junjie Liu, Jinjin Shi & Zhenzhong Zhang. (2022) An oral “Super probiotics” with versatile self-assembly adventitia for enhanced intestinal colonization by autonomous regulating the pathological microenvironment. Chemical Engineering Journal 446, pages 137204.
Crossref
Crossref
Katarina G. Marković, Mirjana Ž. Grujović, Maja G. Koraćević, Danijela D. Nikodijević, Milena G. Milutinović, Teresa Semedo-Lemsaddek & Milan D. Djilas. (2022) Colicins and Microcins Produced by Enterobacteriaceae: Characterization, Mode of Action, and Putative Applications. International Journal of Environmental Research and Public Health 19:18, pages 11825.
Crossref
Crossref
Matthew Lebovich & Lauren B. Andrews. (2022) Surveying the Genetic Design Space for Transcription Factor-Based Metabolite Biosensors: Synthetic Gamma-Aminobutyric Acid and Propionate Biosensors in E. coli Nissle 1917. Frontiers in Bioengineering and Biotechnology 10.
Crossref
Crossref
Shu-Yun Cheng, Tzu-Han Lin & Po-Ting Chen. (2022)
Integration of Multiple Phage Attachment Sites System to Create the Chromosomal T7 System for Protein Production in
Escherichia coli
Nissle 1917
. Journal of Agricultural and Food Chemistry 70:33, pages 10239-10247.
Crossref
Crossref
Matthew ChangSeong Keun Kim, Seung Gyun Woo, Tae Hyun Kim, Seong Hyun Park, Jin Ju Lee, A Young Park, So Hyung Oh, Seong Kun Bak, Seung‐Goo Lee & Dae‐Hee Lee. 2022. Principles in Microbiome Engineering. Principles in Microbiome Engineering
277
304
.
O. V. Dedikova, A. E. Kuchina, I. V. Berezhnaya & I. N. Zakharova. (2022) <i>L. reuteri</i> DSM 17938: from the history of the discovery of the strain to the emergence of evidence-based studies (strain specificity). Meditsinskiy sovet = Medical Council:12, pages 44-48.
Crossref
Crossref
Marcella Pesce, Luisa Seguella, Alessandro Del Re, Jie Lu, Irene Palenca, Chiara Corpetti, Sara Rurgo, Walter Sanseverino, Giovanni Sarnelli & Giuseppe Esposito. (2022) Next-Generation Probiotics for Inflammatory Bowel Disease. International Journal of Molecular Sciences 23:10, pages 5466.
Crossref
Crossref
Elena M. Seco & Luis Ángel Fernández. (2021)
Efficient markerless integration of genes in the chromosome of probiotic
E. coli
Nissle 1917 by bacterial conjugation
. Microbial Biotechnology 15:5, pages 1374-1391.
Crossref
Crossref
Haotian Chen, Yingze Li, Yanjin Wang, Peng Ning, Yajing Shen, Xueyan Wei, Qishuai Feng, Yali Liu, Zhenguang Li, Chang Xu, Siyu Huang, Cuijun Deng, Ping Wang & Yu Cheng. (2022) An Engineered Bacteria-Hybrid Microrobot with the Magnetothermal Bioswitch for Remotely Collective Perception and Imaging-Guided Cancer Treatment. ACS Nano 16:4, pages 6118-6133.
Crossref
Crossref
Aleksandra Maria Kocot, Elżbieta Jarocka-Cyrta & Natalia Drabińska. (2022) Overview of the Importance of Biotics in Gut Barrier Integrity. International Journal of Molecular Sciences 23:5, pages 2896.
Crossref
Crossref
Linlin Zhao, Guobin Yin, Yonglin Zhang, Chaofan Duan, Yang Wang & Zhen Kang. (2022) A comparative study on the genomes, transcriptomes, and metabolic properties of Escherichia coli strains Nissle 1917, BL21(DE3), and MG1655. Engineering Microbiology 2:1, pages 100012.
Crossref
Crossref
M. V. Kuznetsova, J. S. Gizatullina, G. Koraimann & M. Starčič Erjavec. The prospect of creating farm animal probiotics based on genetically modified Escherichia coli strains. The prospect of creating farm animal probiotics based on genetically modified Escherichia coli strains.
Laura I. Sinisterra-Loaiza, Alexandre Lamas, Jose Manuel Miranda, Alberto Cepeda & Alejandra Cardelle-Cobas. 2022. Probiotics for Human Nutrition in Health and Disease. Probiotics for Human Nutrition in Health and Disease
199
230
.
Cristina Méndez-Malagón, Alejandro Egea-Zorrilla, Pedro Perez-Ferrer & Julio Plaza-Diaz. 2022. Probiotics in the Prevention and Management of Human Diseases. Probiotics in the Prevention and Management of Human Diseases
383
396
.
Ana Zúñiga, Miguel Camacho, Hung-Ju Chang, Elsa Fristot, Pauline Mayonove, El-Habib Hani & Jerome Bonnet. (2021)
Engineered
l
-Lactate Responding Promoter System Operating in Glucose-Rich and Anoxic Environments
. ACS Synthetic Biology 10:12, pages 3527-3536.
Crossref
Crossref
Natalia Díaz‐Garrido, Josefa Badia & Laura Baldomà. (2021) Microbiota‐derived extracellular vesicles in interkingdom communication in the gut. Journal of Extracellular Vesicles 10:13.
Crossref
Crossref
Xiaoyu J. Chen, Baojun Wang, Ian P. Thompson & Wei E. Huang. (2021)
Rational Design and Characterization of Nitric Oxide Biosensors in
E. coli
Nissle 1917 and Mini SimCells
. ACS Synthetic Biology 10:10, pages 2566-2578.
Crossref
Crossref
Zhenping Cao, Sisi Lin & Jinyao Liu. (2021) Bacteria-Based Microdevices for the Oral Delivery of Macromolecules. Pharmaceutics 13:10, pages 1610.
Crossref
Crossref
Hua Cao, Tuoyu Zhou, Haibo Tang, Pengya Feng, Gohar Ali, Pu Liu & Xiangkai Li. (2021) Genetically encoded probiotic EcN 1917 alleviates alcohol-induced acute liver injury and restore gut microbiota homeostasis. Journal of Functional Foods 85, pages 104661.
Crossref
Crossref
C.J. ChiangY.P. ChaoA. AliC.H. DayT.J. HoP.N. WangS.C. LinV.V. PadmaW.W. KuoC.Y. Huang. (2021)
Probiotic
Escherichia coli
Nissle inhibits IL-6 and MAPK-mediated cardiac hypertrophy during STZ-induced diabetes in rats
. Beneficial Microbes 12:3, pages 283-293.
Crossref
Crossref
Maria N. Siniagina, Maria I. Markelova, Eugenia A. Boulygina, Alexander V. Laikov, Dilyara R. Khusnutdinova, Sayar R. Abdulkhakov, Natalia A. Danilova, Alfiya H. Odintsova, Rustam A. Abdulkhakov & Tatyana V. Grigoryeva. (2021) Diversity and Adaptations of Escherichia coli Strains: Exploring the Intestinal Community in Crohn’s Disease Patients and Healthy Individuals. Microorganisms 9:6, pages 1299.
Crossref
Crossref
Adam Valcek, Petra Sismova, Kristina Nesporova, Søren Overballe-Petersen, Ibrahim Bitar, Ivana Jamborova, Arie Kant, Jaroslav Hrabak, Jaap A. Wagenaar, Jean-Yves Madec, Peter Damborg, Engeline van Duijkeren, Christa Ewers, Joost Hordijk, Henrik Hasman, Michael S. M. Brouwer & Monika Dolejska. (2021)
Horsing Around: Escherichia coli ST1250 of Equine Origin Harboring Epidemic IncHI1/ST9 Plasmid with
bla
CTX-M-1
and an Operon for Short-Chain Fructooligosaccharide Metabolism
. Antimicrobial Agents and Chemotherapy 65:5.
Crossref
Crossref
Marjorie T. Buss, Pradeep Ramesh, Max Atticus English, Audrey Lee‐Gosselin & Mikhail G. Shapiro. (2021) Spatial Control of Probiotic Bacteria in the Gastrointestinal Tract Assisted by Magnetic Particles. Advanced Materials 33:17.
Crossref
Crossref
Priya J. Sarate, Dagmar Srutkova, Nora Geissler, Martin Schwarzer, Irma Schabussova, Aleksandra Inic-Kanada, Hana Kozakova & Ursula Wiedermann. (2021) Pre- and Neonatal Imprinting on Immunological Homeostasis and Epithelial Barrier Integrity by Escherichia coli Nissle 1917 Prevents Allergic Poly-Sensitization in Mice. Frontiers in Immunology 11.
Crossref
Crossref
Chengyao Wang, Thao Dang, Jasmine Baste, Advait Anil Joshi & Abhinav Bhushan. (2021) A novel standalone microfluidic device for local control of oxygen tension for intestinal‐bacteria interactions. The FASEB Journal 35:2.
Crossref
Crossref
Anton Kan, Ilia Gelfat, Sivaram Emani, Pichet Praveschotinunt & Neel S. Joshi. (2020)
Plasmid Vectors for
in Vivo
Selection-Free Use with the Probiotic
E. coli
Nissle 1917
. ACS Synthetic Biology 10:1, pages 94-106.
Crossref
Crossref
Sukhminderjit Kaur, Rajinder Kaur, Nitu Rani, Swati Sharma & Mahavir Joshi. 2021. Advances in Probiotics for Sustainable Food and Medicine. Advances in Probiotics for Sustainable Food and Medicine
27
43
.
Björn Lorenz, Nairveen Ali, Thomas Bocklitz, Petra Rösch & Jürgen Popp. (2020) Discrimination between pathogenic and non-pathogenic E. coli strains by means of Raman microspectroscopy. Analytical and Bioanalytical Chemistry 412:30, pages 8241-8247.
Crossref
Crossref
Ashok Kumar Madikonda, Akbarpasha Shaikh, Sonali Khanra, Harshita Yakkala, Sailu Yellaboina, Sue Lin‐Chao & Dayananda Siddavattam. (2020)
Metabolic remodeling in
Escherichia coli
MG
1655. A prophage e14‐encoded small
RNA
,
co293
, post‐transcriptionally regulates transcription factors HcaR and FadR
. The FEBS Journal 287:21, pages 4767-4782.
Crossref
Crossref
Pingping Feng, Zhenping Cao, Xinyue Wang, Juanjuan Li & Jinyao Liu. (2020) On‐Demand Bacterial Reactivation by Restraining within a Triggerable Nanocoating. Advanced Materials 32:34.
Crossref
Crossref
Mirelle Geervliet, Laura C. P. Lute, Christine A. Jansen, Victor P. M. G. Rutten, Huub F. J. Savelkoul & Edwin Tijhaar. (2020) Differential immunomodulation of porcine bone marrow derived dendritic cells by E. coli Nissle 1917 and β-glucans. PLOS ONE 15:6, pages e0233773.
Crossref
Crossref
Mareike Schulz, Vasiliki Gaitanoglou, Olena Mantel, Yannick Hövelmann, Florian Hübner, Ulrich Dobrindt & Hans-Ulrich Humpf. (2020) Metabolomics Study on Pathogenic and Non-pathogenic E. coli with Closely Related Genomes with a Focus on Yersiniabactin and Its Known and Novel Derivatives. Metabolites 10:6, pages 221.
Crossref
Crossref
Xiaoli Yu, Changsen Lin, Jing Yu, Qingsheng Qi & Qian Wang. (2019)
Bioengineered
Escherichia coli
Nissle 1917 for tumour‐targeting therapy
. Microbial Biotechnology 13:3, pages 629-636.
Crossref
Crossref
Xiaoming Luo, Haixing Song, Jing Yang, Bin Han, Ye Feng, Yanbing Leng & Zhaoqiong Chen. (2020) Encapsulation of Escherichia coli strain Nissle 1917 in a chitosan―alginate matrix by combining layer-by-layer assembly with CaCl2 cross-linking for an effective treatment of inflammatory bowel diseases. Colloids and Surfaces B: Biointerfaces 189, pages 110818.
Crossref
Crossref
Hongbo Li, Tianqi Zhang, Chunshuang Li, Shan Zheng, Hongjuan Li & Jinghua Yu. (2020) Development of a microencapsulated synbiotic product and its application in yoghurt. LWT 122, pages 109033.
Crossref
Crossref
Bingming Ou, Boyu Jiang, Duo Jin, Ying Yang, Minyu Zhang, Dong Zhang, Haizhou Zhao, Mengxian Xu, Haoliang Song, Wenwen Wu, Mingliang Chen, Ti Lu, Jiachen Huang, Hyesuk Seo, Carolina Garcia, Wanglong Zheng, Weiyi Guo, Yinhua Lu, Yu Jiang, Sheng Yang, Radhey S. Kaushik, Xinchang Li, Weiping Zhang & Guoqiang Zhu. (2020)
Engineered Recombinant
Escherichia coli
Probiotic Strains Integrated with F4 and F18 Fimbriae Cluster Genes in the Chromosome and Their Assessment of Immunogenic Efficacy
in Vivo
. ACS Synthetic Biology 9:2, pages 412-426.
Crossref
Crossref
Zhenping Cao, Xinyue Wang, Yan Pang, Shanshan Cheng & Jinyao Liu. (2019) Biointerfacial self-assembly generates lipid membrane coated bacteria for enhanced oral delivery and treatment. Nature Communications 10:1.
Crossref
Crossref
Pichet Praveschotinunt, Anna M. Duraj-Thatte, Ilia Gelfat, Franziska Bahl, David B. Chou & Neel S. Joshi. (2019) Engineered E. coli Nissle 1917 for the delivery of matrix-tethered therapeutic domains to the gut. Nature Communications 10:1.
Crossref
Crossref
Irina L. Maslennikova, Ekaterina G. Orlova, Julia S. Gizatullina, Marjanca Starčič Erjavec, Natalia P. Loginova, Yana N. Troinich & Marina V. Kuznetsova. (2019) Effect of per oral administration of the ŽP strain, a new potential probiotic, on rats. Acta Biologica Slovenica 62:2, pages 15-25.
Crossref
Crossref
Camille Zimmer & Caetano Dorea. (2019) Enumeration of Escherichia coli in Probiotic Products. Microorganisms 7:10, pages 437.
Crossref
Crossref
Fernando Baquero, Val F. Lanza, Maria-Rosario Baquero, Rosa del Campo & Daniel A. Bravo-Vázquez. (2019) Microcins in Enterobacteriaceae: Peptide Antimicrobials in the Eco-Active Intestinal Chemosphere. Frontiers in Microbiology 10.
Crossref
Crossref
Natalia Diaz-Garrido, María-José Fábrega, Rodrigo Vera, Rosa Giménez, Josefa Badia & Laura Baldomà. (2019) Membrane vesicles from the probiotic Nissle 1917 and gut resident Escherichia coli strains distinctly modulate human dendritic cells and subsequent T cell responses. Journal of Functional Foods 61, pages 103495.
Crossref
Crossref
Clémence Massip, Priscilla Branchu, Nadège Bossuet-Greif, Camille V. Chagneau, Déborah Gaillard, Patricia Martin, Michèle Boury, Thomas Sécher, Damien Dubois, Jean-Philippe Nougayrède & Eric Oswald. (2019) Deciphering the interplay between the genotoxic and probiotic activities of Escherichia coli Nissle 1917. PLOS Pathogens 15:9, pages e1008029.
Crossref
Crossref
Juil Kim & Yuseok Moon. (2019) Worm-Based Alternate Assessment of Probiotic Intervention against Gut Barrier Infection. Nutrients 11:9, pages 2146.
Crossref
Crossref
Kerstin Fiege & Nicole Frankenberg-Dinkel. (2019) Proteine mit ausreichend Häm-Kofaktor beladen. BIOspektrum 25:5, pages 510-512.
Crossref
Crossref
David Ruano-Gallego, Daniel A. Yara, Lorenza Di Ianni, Gad Frankel, Stephanie Schüller & Luis Ángel Fernández. (2019) A nanobody targeting the translocated intimin receptor inhibits the attachment of enterohemorrhagic E. coli to human colonic mucosa. PLOS Pathogens 15:8, pages e1008031.
Crossref
Crossref
Zhenping Cao, Shanshan Cheng, Xinyue Wang, Yan Pang & Jinyao Liu. (2019) Camouflaging bacteria by wrapping with cell membranes. Nature Communications 10:1.
Crossref
Crossref
Sung-Hyun Jo, Han-Gyu Park, Won-Suk Song, Seong-Min Kim, Eun-Jung Kim, Yung-Hun Yang, Jae-Seok Kim, Byung-Gee Kim & Yun-Gon Kim. (2019)
Structural characterization of phosphoethanolamine-modified lipid A from probiotic
Escherichia coli
strain Nissle 1917
. RSC Advances 9:34, pages 19762-19771.
Crossref
Crossref
Halimatun S. Zainuddin, Yanfen Bai & Thomas J. Mansell. (2019)
CRISPR‐based curing and analysis of metabolic burden of cryptic plasmids in
Escherichia coli
Nissle 1917
. Engineering in Life Sciences 19:6, pages 478-485.
Crossref
Crossref
Boyu Jiang, Zhendong Li, Bingming Ou, Qiangde Duan & Guoqiang Zhu. (2019) Targeting ideal oral vaccine vectors based on probiotics: a systematical view. Applied Microbiology and Biotechnology 103:10, pages 3941-3953.
Crossref
Crossref
Robert G. Schaut, Paola M. Boggiatto, Crystal L. Loving & Vijay K. Sharma. (2019) Cellular and Mucosal Immune Responses Following Vaccination with Inactivated Mutant of Escherichia coli O157:H7. Scientific Reports 9:1.
Crossref
Crossref
D. JanoschS. DubbertK. EiteljörgeB.W.K. DiehlU. SonnenbornL.V. PasschierT.M. WassenaarR. von Bünau. (2019)
Anti-genotoxic and anti-mutagenic activity of
Escherichia coli
Nissle 1917 as assessed by
in vitro
tests
. Beneficial Microbes 10:4, pages 449-461.
Crossref
Crossref
Jack Xiaoyu Chen, Harrison Steel, Yin-Hu Wu, Yun Wang, Jiabao Xu, Cordelia P. N. Rampley, Ian P. Thompson, Antonis Papachristodoulou & Wei E. Huang. (2019)
Development of Aspirin-Inducible Biosensors in
Escherichia coli
and SimCells
. Applied and Environmental Microbiology 85:6.
Crossref
Crossref
Ruijuan Li, Linda Helbig, Jun Fu, Xiaoying Bian, Jennifer Herrmann, Michael Baumann, A. Francis Stewart, Rolf Müller, Aiying Li, Daniel Zips & Youming Zhang. (2019) Expressing cytotoxic compounds in Escherichia coli Nissle 1917 for tumor-targeting therapy. Research in Microbiology 170:2, pages 74-79.
Crossref
Crossref
Caroline B. Kurtz, Yves A. MilletMarja K. PuurunenMylène PerreaultMark R. CharbonneauVincent M. Isabella, Jonathan W. KotulaEugene AntipovYossi DagonWilliam S. Denney, David A. Wagner, Kip A. West, Andrew J. DegarAoife M. BrennanPaul F. Miller. (2019)
An engineered
E. coli
Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans
. Science Translational Medicine 11:475.
Crossref
Crossref
Mykola L. Aryayev, Liudmyla I. Senkivska, Nataliya K. Bredeleva & Irina V. Talashova. (2018) Prophylaxis of acute respiratory infections via improving the immune system in late preterm newborns with E. coli strain Nissle 1917: a controlled pilot trial. Pilot and Feasibility Studies 4:1.
Crossref
Crossref
Asmaa Mawad, Yosra A. Helmy, Abdel-Gawad Shalkami, Dipak Kathayat & Gireesh Rajashekara. (2018) E. coli Nissle microencapsulation in alginate-chitosan nanoparticles and its effect on Campylobacter jejuni in vitro. Applied Microbiology and Biotechnology 102:24, pages 10675-10690.
Crossref
Crossref
Leen Boesmans, Mireia Valles-Colomer, Jun Wang, Venessa Eeckhaut, Gwen Falony, Richard Ducatelle, Filip Van Immerseel, Jeroen Raes & Kristin Verbeke. (2018)
Butyrate Producers as Potential Next-Generation Probiotics: Safety Assessment of the Administration of
Butyricicoccus pullicaecorum
to Healthy Volunteers
. mSystems 3:6.
Crossref
Crossref
Kathryn G. Geldart, Sushma Kommineni, Madeline Forbes, Michael Hayward, Gary M. Dunny, Nita H. Salzman & Yiannis N. Kaznessis. (2018)
Engineered
E. coli
Nissle 1917 for the reduction of vancomycin‐resistant
Enterococcus
in the intestinal tract
. Bioengineering & Translational Medicine 3:3, pages 197-208.
Crossref
Crossref
Hui Lee, Haosheng Shen, In Hwang, Hua Ling, Wen Yew, Yung Lee & Matthew Chang. (2018) Targeted Approaches for In Situ Gut Microbiome Manipulation. Genes 9:7, pages 351.
Crossref
Crossref
Hanna Chen, Qian Fang, Qiang Tu, Chenlang Liu, Jia Yin, Yulong Yin, Liqiu Xia, Xiaoying Bian & Youming Zhang. (2018) Identification of a contact-dependent growth inhibition system in the probiotic Escherichia coli Nissle 1917. FEMS Microbiology Letters 365:11.
Crossref
Crossref
Susanne Bury, Manonmani Soundararajan, Richa Bharti, Rudolf von Bünau, Konrad U. Förstner & Tobias A. Oelschlaeger. (2018) The Probiotic Escherichia coli Strain Nissle 1917 Combats Lambdoid Bacteriophages stx and λ. Frontiers in Microbiology 9.
Crossref
Crossref
Kuili Fang, Xing Jin & Seok Hoon Hong. (2018) Probiotic Escherichia coli inhibits biofilm formation of pathogenic E. coli via extracellular activity of DegP. Scientific Reports 8:1.
Crossref
Crossref
Christian Reuter, Mona Alzheimer, Heike Walles & Tobias A. Oelschlaeger. (2018) An adherent mucus layer attenuates the genotoxic effect of colibactin. Cellular Microbiology 20:2, pages e12812.
Crossref
Crossref
Raymond W. Bourdeau, Audrey Lee-Gosselin, Anupama Lakshmanan, Arash Farhadi, Sripriya Ravindra Kumar, Suchita P. Nety & Mikhail G. Shapiro. (2018) Acoustic reporter genes for noninvasive imaging of microorganisms in mammalian hosts. Nature 553:7686, pages 86-90.
Crossref
Crossref
Ricard Solé & Nuria Conde-Pueyo. (2018) Ultrasound approach tracks gut microbes. Nature 553:7686, pages 36-37.
Crossref
Crossref
Teresa Pérez-Berezo, Julien Pujo, Patricia Martin, Pauline Le Faouder, Jean-Marie Galano, Alexandre Guy, Claude Knauf, Jean Claude Tabet, Sophie Tronnet, Frederick Barreau, Maud Heuillet, Gilles Dietrich, Justine Bertrand-Michel, Thierry Durand, Eric Oswald & Nicolas Cenac. (2017) Identification of an analgesic lipopeptide produced by the probiotic Escherichia coli strain Nissle 1917. Nature Communications 8:1.
Crossref
Crossref
M. Hickey. 2017. Probiotic Dairy Products. Probiotic Dairy Products
165
206
.
Lian He, Huijun Yang, Fei Liu, Yiyan Chen, Sijia Tang, Wei Ji, Jianli Tang, Zhudong Liu, Yunjun Sun, Shengbiao Hu, Youming Zhang, Xiong Liu, Weitao Huang, Xuezhi Ding & Liqiu Xia. (2017)
Escherichia coli
Nissle 1917 engineered to express Tum-5 can restrain murine melanoma growth
. Oncotarget 8:49, pages 85772-85782.
Crossref
Crossref
Salvatore Fabbiano, Nicolas Suárez-Zamorano & Mirko Trajkovski. (2017) Host–Microbiota Mutualism in Metabolic Diseases. Frontiers in Endocrinology 8.
Crossref
Crossref
Ruma Raghuvanshi, Archana Chaudhari & G. Naresh Kumar. (2017) 2-Ketogluconic acid and pyrroloquinoline quinone secreting probiotic Escherichia coli Nissle 1917 as a dietary strategy against heavy metal induced damage in rats. Journal of Functional Foods 37, pages 541-552.
Crossref
Crossref
Yosra A. Helmy, Issmat I. Kassem, Anand Kumar & Gireesh Rajashekara. (2017) In Vitro Evaluation of the Impact of the Probiotic E. coli Nissle 1917 on Campylobacter jejuni’s Invasion and Intracellular Survival in Human Colonic Cells. Frontiers in Microbiology 8.
Crossref
Crossref
Sukumar Kandasamy, Anastasia N. Vlasova, David D. Fischer, Kuldeep S. Chattha, Lulu Shao, Anand Kumar, Stephanie N. Langel, Abdul Rauf, Huang-Chi Huang, Gireesh Rajashekara & Linda J. Saif. (2017) Unraveling the Differences between Gram-Positive and Gram-Negative Probiotics in Modulating Protective Immunity to Enteric Infections. Frontiers in Immunology 8.
Crossref
Crossref
Alison J. Hodgkinson, Julie Cakebread, Megan Callaghan, Paul Harris, Rachel Brunt, Rachel C. Anderson, Kelly M. Armstrong & Brendan Haigh. (2017) Comparative innate immune interactions of human and bovine secretory IgA with pathogenic and non-pathogenic bacteria. Developmental & Comparative Immunology 68, pages 21-25.
Crossref
Crossref
Suguru Shigemori & Takeshi Shimosato. (2017) Applications of Genetically Modified Immunobiotics with High Immunoregulatory Capacity for Treatment of Inflammatory Bowel Diseases. Frontiers in Immunology 8.
Crossref
Crossref
L. Pastrana, R. González, N. Estévez, L. Pereira, I. Rodríguez Amado, P. Fuciños, C. Fuciños, M.L. Rúa, E. Alonso & R. Troncoso. 2017. Current Developments in Biotechnology and Bioengineering. Current Developments in Biotechnology and Bioengineering
165
200
.
Kiran R. Surati & Pooja A. Sathe. (2016) Schiff base pyrazolone complexes of iron (III): synthesis, characterization, antimicrobial and antioxidant activity. Medicinal Chemistry Research 25:12, pages 2742-2751.
Crossref
Crossref
Ruma Raghuvanshi, Archana Chaudhari & G. Naresh Kumar. (2016) Amelioration of cadmium- and mercury-induced liver and kidney damage in rats by genetically engineered probiotic Escherichia coli Nissle 1917 producing pyrroloquinoline quinone with oral supplementation of citric acid. Nutrition 32:11-12, pages 1285-1294.
Crossref
Crossref
Ulrich Sonnenborn. (2016)
Escherichia coli
strain Nissle 1917—from bench to bedside and back: history of a special
Escherichia coli
strain with probiotic properties
. FEMS Microbiology Letters 363:19, pages fnw212.
Crossref
Crossref
Jennifer K. Spinler, Caná L. Ross & Tor C. Savidge. (2016) Probiotics as adjunctive therapy for preventing Clostridium difficile infection – What are we waiting for?. Anaerobe 41, pages 51-57.
Crossref
Crossref
Bingming Ou, Ying Yang, Wai Liang Tham, Lin Chen, Jitao Guo & Guoqiang Zhu. (2016) Genetic engineering of probiotic Escherichia coli Nissle 1917 for clinical application. Applied Microbiology and Biotechnology 100:20, pages 8693-8699.
Crossref
Crossref
Harshana Sabharwal, Christoph Cichon, Tobias A. Ölschläger, Ulrich Sonnenborn & M. Alexander Schmidt. (2016) Interleukin-8, CXCL1, and MicroRNA miR-146a Responses to Probiotic Escherichia coli Nissle 1917 and Enteropathogenic E. coli in Human Intestinal Epithelial T84 and Monocytic THP-1 Cells after Apical or Basolateral Infection. Infection and Immunity 84:9, pages 2482-2492.
Crossref
Crossref
Ying Yang, Yi Yang, Bingming Ou, Pengpeng Xia, Mingxu Zhou, Luan Li & Guoqiang Zhu. (2016) The flagellin hypervariable region is a potential flagella display domain in probiotic Escherichia coli strain Nissle 1917. Archives of Microbiology 198:7, pages 603-610.
Crossref
Crossref
María-Alexandra Cañas, Rosa Giménez, María-José Fábrega, Lorena Toloza, Laura Baldomà & Josefa Badia. (2016) Outer Membrane Vesicles from the Probiotic Escherichia coli Nissle 1917 and the Commensal ECOR12 Enter Intestinal Epithelial Cells via Clathrin-Dependent Endocytosis and Elicit Differential Effects on DNA Damage. PLOS ONE 11:8, pages e0160374.
Crossref
Crossref
Elina Manzhalii, Daniel Hornuss & Wolfgang Stremmel. (2016)
Intestinal-borne dermatoses significantly improved by oral application of
Escherichia coli
Nissle 1917
. World Journal of Gastroenterology 22:23, pages 5415.
Crossref
Crossref
Claudia F. Martinez de la Peña, Glen D. Armstrong, Margarita M. P. Arenas-Hernández & Roberto J. Cieza. 2016. Escherichia coli in the Americas. Escherichia coli in the Americas
281
299
.
Lorena Toloza, Rosa Giménez, María Jose Fábrega, Carina Shianya Alvarez, Laura Aguilera, María Alexandra Cañas, Raquel Martín-Venegas, Josefa Badia & Laura Baldomà. (2015) The secreted autotransporter toxin (Sat) does not act as a virulence factor in the probiotic Escherichia coli strain Nissle 1917. BMC Microbiology 15:1.
Crossref
Crossref
Marjanca Starčič Erjavec, Živa Petkovšek, Marina V. Kuznetsova, Irina L. Maslennikova & Darja Žgur-Bertok. (2015) Strain ŽP — the first bacterial conjugation-based “kill”–“anti-kill” antimicrobial system. Plasmid 82, pages 28-34.
Crossref
Crossref
Ashish Kumar Singh, Sumeet Kumar Pandey, Gourav Saha & Naresh Kumar Gattupalli. (2015) Pyrroloquinoline quinone (PQQ) producing Escherichia coli Nissle 1917 (EcN) alleviates age associated oxidative stress and hyperlipidemia, and improves mitochondrial function in ageing rats. Experimental Gerontology 66, pages 1-9.
Crossref
Crossref
Jonathan Nzakizwanayo, Sandeep Kumar, Lesley A. Ogilvie, Bhavik A. Patel, Cinzia Dedi, Wendy M. Macfarlane & Brian V. Jones. (2015) Disruption of Escherichia coli Nissle 1917 K5 Capsule Biosynthesis, through Loss of Distinct kfi genes, Modulates Interaction with Intestinal Epithelial Cells and Impact on Cell Health. PLOS ONE 10:3, pages e0120430.
Crossref
Crossref
Trudy Wassenaar, Anke Zschüttig, Claudia Beimfohr, Thomas Geske, Christian Auerbach, Helen Cook, Kurt Zimmermann & Florian Gunzer. (2015)
Virulence genes in a probiotic
E. oli
product with a recorded long history of safe use
. European Journal of Microbiology and Immunology 5:1, pages 81-93.
Crossref
Crossref
M. Ozen & E.C. Dinleyici. (2015) The history of probiotics: the untold story. Beneficial Microbes 6:2, pages 159-165.
Crossref
Crossref
E.E.C. Rigobelo, N. Karapetkov, S.A. Maestá, F.A. Ávila & D. McIntosh. (2015)
Use of probiotics to reduce faecal shedding of Shiga toxin-producing
Escherichia coli
in sheep
. Beneficial Microbes 6:1, pages 53-60.
Crossref
Crossref
J. E. Dalziel, V. Mohan, J. Peters, R. C. Anderson, P. K. Gopal & N. C. Roy. (2015) The probiotic Escherichia coli Nissle 1917 inhibits propagating colonic contractions in the rat isolated large intestine. Food & Function 6:1, pages 256-263.
Crossref
Crossref
Xiaoying Bian, Fan Huang, Hailong Wang, Thorsten Klefisch, Rolf Müller & Youming Zhang. (2014)
Heterologous Production of Glidobactins/Luminmycins in
Escherichia coli
Nissle Containing the Glidobactin Biosynthetic Gene Cluster from
Burkholderia
DSM7029
. ChemBioChem 15:15, pages 2221-2224.
Crossref
Crossref
Marten Reister, Klaus Hoffmeier, Nicolas Krezdorn, Bjoern Rotter, Chunguang Liang, Stefan Rund, Thomas Dandekar, Ulrich Sonnenborn & Tobias A. Oelschlaeger. (2014) Complete genome sequence of the Gram-negative probiotic Escherichia coli strain Nissle 1917. Journal of Biotechnology 187, pages 106-107.
Crossref
Crossref
Alla Splichalova, Igor Splichal, Ulrich Sonnenborn & Vojtech Rada. (2014) A modified MacConkey agar for selective enumeration of necrotoxigenic E. coli O55 and probiotic E. coli Nissle 1917. Journal of Microbiological Methods 104, pages 82-86.
Crossref
Crossref
Ashish K. Singh, Sumeet K. Pandey & Gattupalli Naresh Kumar. (2014)
Pyrroloquinoline Quinone-Secreting Probiotic
Escherichia coli
Nissle 1917 Ameliorates Ethanol-Induced Oxidative Damage and Hyperlipidemia in Rats
. Alcoholism: Clinical and Experimental Research 38:7, pages 2127-2137.
Crossref
Crossref
Sumeet Pandey, Ashish Singh, Prasant Kumar, Archana Chaudhari & G. Nareshkumar. (2014) Probiotic Escherichia coli CFR 16 Producing Pyrroloquinoline Quinone (PQQ) Ameliorates 1,2-Dimethylhydrazine-Induced Oxidative Damage in Colon and Liver of Rats. Applied Biochemistry and Biotechnology 173:3, pages 775-786.
Crossref
Crossref
Zuzana Matuskova, Eva Anzenbacherova, Rostislav Vecera, Helena Tlaskalova-Hogenova, Milan Kolar & Pavel Anzenbacher. (2014) Administration of a Probiotic Can Change Drug Pharmacokinetics: Effect of E. coli Nissle 1917 on Amidarone Absorption in Rats. PLoS ONE 9:2, pages e87150.
Crossref
Crossref
Helen M. Becker, Aretussa Apladas, Michael Scharl, Michael Fried & Gerhard Rogler. (2014) Probiotic <b><i>Escherichia coli</i></b> Nissle 1917 and Commensal <b><i>E. coli</i></b> K12 Differentially Affect the Inflammasome in Intestinal Epithelial Cells. Digestion 89:2, pages 110-118.
Crossref
Crossref
Joris Beld, Eva C. Sonnenschein, Christopher R. Vickery, Joseph P. Noel & Michael D. Burkart. (2014) The phosphopantetheinyl transferases: catalysis of a post-translational modification crucial for life. Nat. Prod. Rep. 31:1, pages 61-108.
Crossref
Crossref
Xiaoying Bian, Jun Fu, Alberto Plaza, Jennifer Herrmann, Dominik Pistorius, A. Francis Stewart, Youming Zhang & Rolf Müller. (2013) In Vivo Evidence for a Prodrug Activation Mechanism during Colibactin Maturation. ChemBioChem 14:10, pages 1194-1197.
Crossref
Crossref
Brady F. Cress, Robert J. Linhardt & Mattheos A. G. Koffas. (2013) Draft Genome Sequence of Escherichia coli Strain Nissle 1917 (Serovar O6:K5:H1). Genome Announcements 1:2.
Crossref
Crossref
Sarah E. Ongley, Xiaoying Bian, Brett A. Neilan & Rolf Müller. (2013) Recent advances in the heterologous expression of microbial natural product biosynthetic pathways. Natural Product Reports 30:8, pages 1121.
Crossref
Crossref
Stefan A. Rund, Holger Rohde, Ulrich Sonnenborn & Tobias A. Oelschlaeger. (2013) Antagonistic effects of probiotic Escherichia coli Nissle 1917 on EHEC strains of serotype O104:H4 and O157:H7. International Journal of Medical Microbiology 303:1, pages 1-8.
Crossref
Crossref
Anja Troge, Wolfgang Scheppach, Bjoern O. Schroeder, Stefan A. Rund, Klaus Heuner, Jan Wehkamp, Eduard F. Stange & Tobias A. Oelschlaeger. (2012) More than a marine propeller – the flagellum of the probiotic Escherichia coli strain Nissle 1917 is the major adhesin mediating binding to human mucus. International Journal of Medical Microbiology 302:7-8, pages 304-314.
Crossref
Crossref
Wolfgang Kruis, Sigrun Chrubasik, Stephan Boehm, Christiane Stange & Juergen Schulze. (2011) A double-blind placebo-controlled trial to study therapeutic effects of probiotic Escherichia coli Nissle 1917 in subgroups of patients with irritable bowel syndrome. International Journal of Colorectal Disease 27:4, pages 467-474.
Crossref
Crossref
Jürgen Schulze. (2012) Das probiotische Konzept. Pharmazie in unserer Zeit 41:2, pages 110-116.
Crossref
Crossref
Christin Weise, Yan Zhu, Dennis Ernst, Anja A. Kühl & Margitta Worm. (2011) Oral administration of Escherichia coli Nissle 1917 prevents allergen-induced dermatitis in mice. Experimental Dermatology 20:10, pages 805-809.
Crossref
Crossref
Viktoria Hancock, Rebecca Munk Vejborg & Per Klemm. (2010) Functional genomics of probiotic Escherichia coli Nissle 1917 and 83972, and UPEC strain CFT073: comparison of transcriptomes, growth and biofilm formation. Molecular Genetics and Genomics 284:6, pages 437-454.
Crossref
Crossref
P. Bosi & P. Trevisi. (2010) New topics and limits related to the use of beneficial microbes in pig feeding. Beneficial Microbes 1:4, pages 447-454.
Crossref
Crossref
Rebecca Munk Vejborg, Carsten Friis, Viktoria Hancock, Mark A. Schembri & Per Klemm. (2010) A virulent parent with probiotic progeny: comparative genomics of Escherichia coli strains CFT073, Nissle 1917 and ABU 83972. Molecular Genetics and Genomics 283:5, pages 469-484.
Crossref
Crossref
Jason Paul Lynch, Coral González-Prieto, Analise Reeves, Urmila Powale, Neha Godbole, Jacqueline Tremblay, Florian Schmidt, Hidde Ploegh, Jonathan Glickman, John Leong, Charles Shoemaker, Wendy Garrett & Cammie Lesser. (2022) Engineered <i>E. coli</i> for the Targeted Deposition of Therapeutic Payloads to Sites of Disease. SSRN Electronic Journal.
Crossref
Crossref